Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 23891-23900 Newer>

The Motley Fool June 13, 2007 Billy Fisher	The Best Retail Stock for 2007 Revisited So far it isn't even a contest for the Best Retail Stock for 2007 -- Chipotle has taken a commanding lead with a return of 36.3%.
The Motley Fool June 13, 2007 Rick Aristotle Munarriz	My Tweeter Done Died Consumer electronics stalwart Tweeter files for Chapter 11. With looser shackles, maybe Tweeter will be able to give its latest makeover a better shot. Investors, take note.
The Motley Fool June 13, 2007 Brian Orelli	Evaluating a One-Trick Pony There is no doubt that investors should have bought Onyx Pharmaceuticals at its lows last December: The stock has tripled since then. The more important question is, what should you do now? Let's take a look at where Onyx is going.
The Motley Fool June 13, 2007 Jeff Hwang	Gaming Roundup: WSOP, LVS, and ASCA The latest from Vegas: Notes from the Las Vegas Sands shareholder meeting... From the Ameristar Casinos shareholder meeting... etc.
The Motley Fool June 13, 2007 Brian Lawler	ViroPharma Is on Its Way ViroPharma completes preliminary enrollment in a study of one of its drug candidates. Investors, take note.
The Motley Fool June 13, 2007 Tim Beyers	Who's Filing Now? Investors, take a look at what lurks in Friday's late filings. SUPERVALU... Harley-Davidson... BioSante Pharmaceuticals... etc.
The Motley Fool June 13, 2007 Billy Fisher	Homebuilding Is Booming ... in Mexico Homex's performance suggests that things may be better for homebuilders south of the Rio Grande. There are a couple of possible risks to consider before you dive head-first into this stock, though.
The Motley Fool June 13, 2007 Brian Lawler	Tracking Vertex The pharmaceutical updates investors on the progress of its lead compound.
The Motley Fool June 13, 2007 Rich Smith	Pepsi Confronts Coke Back in the (Former) USSR The soft drink titan buys Ukraine's biggest juice concern. Investors, take note.
The Motley Fool June 13, 2007 Billy Fisher	The Best Drug Stock for 2007 Revisited With half of the season left, anything can happen and no lead is safe -- especially in the biotech/pharmaceutical industry. For now the leader, Endo Pharmaceutical, is head and shoulders above the rest.
<Older 23891-23900 Newer> Return to current articles.